Group 6 Copy 536
1
Please wait...

About This Project

The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

Blast off!

Browse Other Projects on Experiment

Related Projects

The Dogs of Chernobyl Research Initiative

The Chernobyl disaster site has hundreds of feral dogs that are in need of care. A team of students from...

Crowdcuring the Blues: People, Technology and Research Against Depression

Depression is not a choice, but we can choose to do something about it. Depression is a single label used...

Finding a Cure for Mitochondrial DNA Diseases through COX2 Variations to Restore Cell Function

Inherited and acquired mutations in the mitochondrial DNA can lead to several debilitating diseases, including...

Backer Badge Funded